The Patent Finder

Angiochem Inc.

Also on record
Records under this name other than the patents Angiochem Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Angiochem Inc.

PatentTitleStatus Expires Confidence
US 8,828,925Etoposide and Doxorubicin Conjugates for Drug Delivery
Lapsed on the fee record
Ended Sep 9, 2026 · High confidence
Lapsed on the fee recordEnded Sep 9, 2026High confidence
US 9,914,754Conjugates of neurotensin or neurotensin analogs and uses thereof
Lapsed on the fee record
Ended Mar 13, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2026From the USPTO record
US 9,713,646Potentiation of anticancer agents
Lapsed on the fee record
Ended Jul 25, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 25, 2025From the USPTO record
US 7,557,182Molecules for Transporting a Compound Across the Blood-Brain Barrier
Term ended
Term ended Jul 21, 2025 · High confidence
Term endedTerm ended Jul 21, 2025High confidence
US 8,828,949Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
Term ended
Term ended Jul 21, 2025 · High confidence
Term endedTerm ended Jul 21, 2025High confidence
US 9,365,634Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
Lapsed on the fee record
Ended Jun 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 14, 2024From the USPTO record
US 9,173,891Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
Lapsed on the fee record
Ended Nov 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2023From the USPTO record
US 7,902,156Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
Lapsed on the fee record
Ended Mar 8, 2023 · High confidence
Lapsed on the fee recordEnded Mar 8, 2023High confidence
US 9,687,561Peptide-dendrimer conjugates and uses thereof
Lapsed on the fee record
Ended Jun 27, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 27, 2021From the USPTO record
US 8,921,314Conjugates of GLP-1 agonists and uses thereof
Lapsed on the fee record
Ended Dec 30, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 30, 2018From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited